BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27998644)

  • 1. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Schiffmann R; Hughes DA; Linthorst GE; Ortiz A; Svarstad E; Warnock DG; West ML; Wanner C;
    Kidney Int; 2017 Feb; 91(2):284-293. PubMed ID: 27998644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Changing Landscape of Fabry Disease.
    Svarstad E; Marti HP
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):569-576. PubMed ID: 32132142
    [No Abstract]   [Full Text] [Related]  

  • 3. Anderson-Fabry disease.
    Di Toro A; Favalli V; Arbustini E
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e1-e5. PubMed ID: 29538136
    [No Abstract]   [Full Text] [Related]  

  • 4. Fabry disease: Review and experience during newborn screening.
    Hsu TR; Niu DM
    Trends Cardiovasc Med; 2018 May; 28(4):274-281. PubMed ID: 29100912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
    Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
    Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney in Fabry's disease.
    Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
    Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease: diagnostic methods in nephrology practice.
    Vujkovac B
    Clin Nephrol; 2017 Supplement 1; 88(13):44-47. PubMed ID: 28601129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabry disease previously diagnosed as Henoch-Schonlein purpura.
    Kim JH; Han DH; Park MY; Choi SJ; Kim JK; Hwang SD; Jin SY
    Korean J Intern Med; 2015 Nov; 30(6):925-7. PubMed ID: 26552470
    [No Abstract]   [Full Text] [Related]  

  • 10. Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.
    Ezgu F; Alpsoy E; Bicik Bahcebasi Z; Kasapcopur O; Palamar M; Onay H; Ozdemir BH; Topcuoglu MA; Tufekcioglu O
    Orphanet J Rare Dis; 2022 Mar; 17(1):90. PubMed ID: 35236382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity.
    Allen LE; Cosgrave EM; Kersey JP; Ramaswami U
    Br J Ophthalmol; 2010 Dec; 94(12):1602-5. PubMed ID: 20576773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
    Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
    Frustaci A; Russo MA; Chimenti C
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27486136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fabry disease].
    Subran B; Montagner C; London J; Lidove O; Mauhin W
    Rev Prat; 2020 May; 70(5):537-540. PubMed ID: 33058644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus for the study and treatment of Fabry disease. GETER Foundation].
    García de Lorenzo A;
    Med Clin (Barc); 2011 Jul; 137(4):178-83. PubMed ID: 21529855
    [No Abstract]   [Full Text] [Related]  

  • 16. Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community.
    Wanner C; Ortiz A; Wilcox WR; Hopkin RJ; Johnson J; Ponce E; Ebels JT; Batista JL; Maski M; Politei JM; Martins AM; Banikazemi M; Linhart A; Mauer M; Oliveira JP; Weidemann F; Germain DP
    Mol Genet Metab; 2023 Jul; 139(3):107603. PubMed ID: 37236007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidisciplinary treatment in the long-term management of Fabry disease].
    ;
    Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):949-955. PubMed ID: 37528032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].
    Lidove O; Bekri S; Goizet C; Khau Van Kien A; Aractingi S; Knebelmann B; Choukroun G; Tsimaratos M; Redonnet-Vernhet I; Lacombe D; Jaussaud R
    Presse Med; 2007; 36(7-8):1084-97. PubMed ID: 17276649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
    Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
    Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and management of kidney transplant recipients with Fabry disease: a review.
    Yu B; Atta MG; Brennan DC; Kant S
    J Nephrol; 2024 Apr; 37(3):561-571. PubMed ID: 38227277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.